Ocra (Abelmoschus esculentus)

Okra (Abelmoschus esculentus) is a flowering plant whose soluble fiber, primarily mucilaginous polysaccharides and myricetin, supports blood glucose and lipid regulation. These bioactives inhibit alpha-glucosidase activity and bind bile acids in the gut, reducing postprandial glucose spikes and LDL cholesterol absorption.

Origin & History

Okra (Abelmoschus esculentus) is a flowering plant in the mallow family native to Africa, now cultivated globally for its edible green seed pods. The mucilaginous pods are harvested before maturity and consumed whole as a vegetable or processed into powders and extracts, containing polysaccharides, phenolic compounds, and flavonoids.

Historical & Cultural Context

The research dossier does not contain information regarding okra's historical or traditional medicinal use. The reviewed literature focuses exclusively on contemporary clinical research without addressing traditional medicine applications.

Health Benefits

• Reduces fasting blood glucose by up to 39.58 mg/dL based on meta-analysis of 9 RCTs (Strong evidence)
• Lowers LDL cholesterol by 13.30-2.48 mg/dL according to 2024 meta-analysis (Strong evidence)
• Decreases HbA1c by 0.46 mg/dL in prediabetic and diabetic populations (Strong evidence)
• Improves liver function markers including aspartate aminotransferase per systematic review of 12 trials (Moderate evidence)
• Enhances insulin sensitivity (HOMA-IR) particularly at doses >4g/day in type 2 diabetes patients (Moderate evidence)

How It Works

Okra's mucilaginous polysaccharides form a viscous gel in the gastrointestinal tract that slows carbohydrate digestion and glucose absorption by inhibiting alpha-glucosidase and alpha-amylase enzymes. The flavonoid myricetin activates GLUT4 translocation via the PI3K/Akt insulin signaling pathway, enhancing peripheral glucose uptake in skeletal muscle cells. Additionally, soluble fiber in okra binds bile acids and cholesterol micelles in the intestinal lumen, reducing enterohepatic recirculation and upregulating hepatic LDL receptor expression.

Scientific Research

Multiple meta-analyses demonstrate okra's cardiometabolic benefits, including a 2024 analysis (PMID: 39726865) of 9 RCTs showing significant improvements in cholesterol and glucose markers, and a 2025 systematic review (PMID: 40007206) of 12 trials with 770 participants confirming effects on metabolic parameters. A diabetes-specific meta-analysis (PMID: 40867089) found enhanced insulin resistance improvements at higher doses.

Clinical Summary

A meta-analysis of 9 RCTs demonstrated that okra supplementation significantly reduces fasting blood glucose by up to 39.58 mg/dL in individuals with prediabetes or type 2 diabetes. A 2024 meta-analysis reported LDL cholesterol reductions ranging from 2.48 to 13.30 mg/dL across trials, indicating consistent but variably sized lipid-lowering effects. HbA1c was reduced by approximately 0.46% in diabetic and prediabetic populations, suggesting meaningful long-term glycemic improvement. Evidence quality is considered strong given RCT-level data, though individual study sample sizes tend to be modest and standardization of okra preparations varies across trials.

Nutritional Profile

Per 100g raw okra: Calories 33 kcal, Water 89.6g, Carbohydrates 7.45g, Dietary Fiber 3.2g (primarily soluble mucilaginous polysaccharides including pectin and galactomannan), Protein 1.93g, Fat 0.19g. Key vitamins: Vitamin C 23mg (26% DV), Vitamin K1 31.3mcg (26% DV), Folate 60mcg (15% DV), Vitamin B6 0.215mg (13% DV), Vitamin A (as beta-carotene) 36mcg RAE. Key minerals: Magnesium 57mg (14% DV), Potassium 299mg (6% DV), Calcium 82mg (8% DV), Phosphorus 61mg, Iron 0.62mg, Zinc 0.58mg, Manganese 0.788mg (34% DV). Bioactive compounds: Quercetin 21.0mg/100g, Rutin (quercetin-3-rutinoside) 68.0-82.0mg/100g (primary flavonoid responsible for glucose-lowering effects), Isoquercitrin, Kaempferol 0.5-1.2mg/100g, Myricetin trace amounts, Catechins including epicatechin. Mucilage polysaccharides (1.5-3.0g/100g): composed of rhamnose, galactose, glucose, xylose and galacturonic acid — key mediators of cholesterol and glucose binding in the gut. Lectins present in seeds. Pectin approximately 0.5-1.0g/100g contributes to soluble fiber bioactivity. Bioavailability notes: Fat-soluble compounds (beta-carotene, Vitamin K) have enhanced absorption when okra is consumed with dietary fat. Boiling reduces quercetin content by approximately 30-50%; steaming or roasting preserves more polyphenols. Mucilage viscosity decreases significantly with prolonged cooking, reducing its cholesterol-binding capacity. Oxalic acid content (37mg/100g) is low and unlikely to significantly impair calcium bioavailability at typical serving sizes.

Preparation & Dosage

Clinical studies used okra powder or extract at doses ranging from 125-40,000 mg/day, with optimal effects at ≤3,000 mg/day for general metabolic benefits and >4,000 mg/day for insulin resistance. Most trials lasted 2-12 weeks, with shorter durations showing more pronounced effects. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Chromium, Cinnamon, Alpha-lipoic acid, Bitter melon, Fenugreek

Safety & Interactions

Okra is generally well tolerated at dietary and supplemental doses, with gastrointestinal side effects such as bloating and loose stools reported at higher intakes due to its high mucilage content. Okra contains moderate levels of vitamin K and oxalates, which may be relevant for individuals on warfarin anticoagulation therapy or those prone to calcium oxalate kidney stones. Its glucose-lowering effect may potentiate the hypoglycemic action of metformin, sulfonylureas, and insulin, warranting blood glucose monitoring when combining treatments. Safety data in pregnancy and lactation are insufficient to make a definitive recommendation, and caution is advised.